How well do we manage families with genetic problems?

I Wellens HJJ, Brugada P, Penn OC, Gorgels AP, Smeets J. Pre-excitation svndromes: clinical presentation, course and therapy. In: Zipes DP, Jalife J, eds. Cardiac electrophvsiology: from cell to bedside. Philadelphia: W B Saunders, 1990:691-702. 2 Klein GJ, Bashore TM, Sellers TD, Pritchett ELC, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl3' Med 1979;301:1080-5. 3 Cox JL, Gallagher JJ, Cain ME. Experience with 118 consecutive patients undergoing operation for the Wolff-Parkinson-White syndrome. J7 Cardiovasc Surg 1985;90:490-501. 4 Fisher JD, Brodman R, Kim SG. Matos JA, Brodman LE, Wallerson D, Waspe LE. Attempted nonsurgical electrical ablation of accessorv pathways sia the coronary sinus in the WolffParkinson-White syndrome. J Am Coll Cardiol 1984;4:685-94. 5 Ward DE, Camm AJ. Treatment of tachycardias associated with the Wolff Parkinson White syndrome by transvenous electrical ablation of accessory pathways. Br Heart) 1985;53:64-8. 6 Bardy GH, Ivey TD, Stewart RBC, Johnson G, Greene HL. Developments, complications and limitations of catheter-mediated electrical ablation of posterior accessory atrioventricular pathways. Am 7 Cardiol 1988;61:309-16. 7 Morady F, Scheinman MM, Kou WH, Griffin JC, Dick M, Herre J, et al. Long-term results of catheter ablation of a posteroseptal accessory atrioventricular connection in 48 patients. Circulation 1989;79: 1160-70. 8 Warin JF, Haisaguerre M, D'Ivernois C, Lematayer P, Montserrat P. Catheter ablation of accessory pathways: technique and results in 248 patients. PACE 1990;13:1609-14. 9 Evans GT Jr, Scheinmann MM, Zipes DP, and Executive Committee of the Registry. The percutaneous cardiac mapping and ablation registry: final summary of results. PACE 1988;11: 1621-6. 10 Cunningham D, Rowland E, Rickards AF. A new low energy power source for catheter ablation. PACE 1986;9:1389-90. 11 Lemery R, Talajic M, Roy D, Coutu B, Lavalee E, Cartier R. Low energy DC ablation in patients with the Wolff-Parkinson-White syndrome: clinical outcome according to accessory pathway location [abstract]. PACE 1991;14(4 Pt II):670. 12 Borgreffe M, Budde T, Podczeck A, Breithardt G. High frequency alternating current ablation of an accessory pathway in humans. JAm Coll Cardiol 1987;10:576-82. 13 Huang SK. Advances in application of radiofrequency current to catheter ablation therapy. PACE 1991;14:28-42. 14 Jackman W, Wang X, Friday KJ, Roman CA, Moulton KP, Beckman KJ, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N EnglJ7 Med 1991;324:16051l. 15 Kuck K-H, Schluter M, Geiger M, Siebels J, Duckreck W. Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet 1992;337:1557-61. 16 Calkins H, Sousa J, El-Atassi R, Rosenheck S, De Buitleir M, Kou WG, et al. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single, electrophysiologic test. N EnglJ Med 1991;324:1612-8. 17 Langberg JJ, Chin M, Schamp DJ, Lee MA, Goldberger J, Pederson DN, et al. Ablation of the atrioventricular junction with radiofrequency energy using a new electrode catheter. Am J Cardiol 1991;67:142-7. 18 Ruskin JN. The cardiac arrhythmia suppression trial (CAST). N Englj Med 1989;321:386-8. 19 De Buitleir M, Sousa J, Calkins H, Bolling SF, El Atassi R, Kou WH, et al. Dramatic reduction in medical care costs associated with radiofrequency catheter ablation of accessory pathways [abstract]. 7 Am Coll Cardiol 1991;17(suppl A): 109.